Term
|
Definition
Muscarinic receptors, nicotinic at high doses
metabolized by AChesterase
produces parasympathetic effects
Used in paralytic ileus and OAG
dangerous in asthmatics, hypothyroidism, GI obstruction |
|
|
Term
|
Definition
Muscarinic agonist, nicotinic at high doses
not metabolized by AChesterase
produces parasympathetic effects
used in OAG |
|
|
Term
|
Definition
Selective Muscarinic agonist
not metabolized by AChesterase
produces parasympathetic effects
Used in post-operative ileus and urinary retention |
|
|
Term
|
Definition
Selective Nicotinic agonist
Crosses the BBB
Produces excitation, addiction, increased arousal (amygdala, thalamus)
Stimulation of autonomic ganglia, increases GI tone
Used to aid in smoking cessation, ulcerative colitis, and Tourette's Syndrome
Side effects: nausea, vomiting
Associated with Mesolimbic reward system |
|
|
Term
|
Definition
Partial agonist at the Alpha4Beta1 nicotinic receptor
Activates nicotinic receptors somewhat less than nicotine
Blocks nicotines access to the receptor
Used in smoking cessation
Side effects: neuropsychiatric symptoms |
|
|
Term
|
Definition
Blocks AChesterase
Enhances the action of ACh at nicotinic receptors in high doses
Increases muscular contraction
Used as a myasthenia gravis diagnostic tool because it only lasts 5-15 minutes
|
|
|
Term
|
Definition
Blocks AChesterase to enhance ACh
Causes constriction of ciliary muscle
Used in miotic glaucoma
30 min - 2 hour duration
Crosses the BBB |
|
|
Term
|
Definition
Blocks AChesterase to enhance ACh
Enhances action of ACh at nicotinic receptors at high doses
Used for myasthenia gravis (with atropine)
Used in gut/bladder atony or to reverse paralysis produced by skeletal muscle blockers
30 min - 2 hour duration |
|
|
Term
|
Definition
Blocks AChesterase
Modest improvements in memory and cognition
Used in Alzheimer's
24 hour duration
Crosses BBB
Available in pill or patch |
|
|
Term
|
Definition
Blocks AChesterase
Modest improvements in memory and cognition
Used in Alzheimer's
12 hour duration
Also enhances ACh binding to nicotinic receptors
Side effects: nausea, diarrhea, insomnia |
|
|
Term
|
Definition
Irreversibly binds AChesterase
Produces overstimulation of muscarinic receptors
SLUD
Side effects: bronchoconstriction, miosis, sweating, bradycardia, hypotension, pulmonary edema, respiratory paralysis, ataxia, confusion, convulsions, coma
Atropine will block muscarinic activation
Pralidoxime will reactive AChesterase |
|
|
Term
|
Definition
Blocks release of ACh into the synapse by cleaving SNAP25
Blocks effects of ACh at muscarinic receptors
Used for blepharospasm, cosmetic
Can cause excessive muscle paralysis |
|
|
Term
|
Definition
Blocks ACh activation of muscarinic receptors
Produces: tachycardia, prolonged mydriasis, inhibited secretions, constipation, retention, CNS excitement
No effect on blood vessesl
Used as a pre-anesthetic, anti-spasmodic, and anti-diarrheal
Crosses the BBB
Can be dangerous in OAG |
|
|
Term
|
Definition
Blocks ACh activation of muscarinic receptors
Bronchodilator
Used in COPD
Does not cross the BBB |
|
|
Term
|
Definition
Blocks every ganglionic nicotinic receptor in sympathetic and parasympathetic system. Thus is also blocks the adrenergic release of NE
Causes vasodilation, hypotension, tachycardia, mydriasis, reduced GI tone, decreased secretions, xerostomia, and decreased genital stimulation
Used in AAA and to rapidly control BP |
|
|
Term
|
Definition
Non-depolarizing skeletal nicotinic receptor blocker
Causes muscle paralysis
Used to eliminate muscle movements during surgery
Side effects: hypotension due to mast cell degranulation
Cam also block neuronal nicotinic receptors at high doses
2 hour duration
Does not cross BBB
Reversed by neostigmine + atropine |
|
|
Term
|
Definition
Non-depolarizing skeletal nicotinic receptor blocker
Causes muscle paralysis
Used in surgery
Side effects: less hypotension than tubocurarine
1 - 1.5 hour duration
Reversed by neostigmine + atropine
|
|
|
Term
|
Definition
Depolarizing skeletal muscle nicotinic receptor blocker
Causes muscle paralysis
Used in endotracheal tube insertion
Lasts very short time
Metabolized by AChesterase
Cannot be reversed
Alternative: Rocuronium |
|
|
Term
|
Definition
Reactives ACh that has been blocked by irreversible anti-AChesterase
Reduces over-activation of muscarinic receptors
Sarin antidote |
|
|
Term
|
Definition
Skin, mucosa
Constriction of skeletal muscle BV
Constriction of ab viscera BV
Constriction of pulmonary BV
Contraction of GI sphincters
Contraction of bladder
Male and female orgasm and ejaculation
Uterine contraction in pregnant women
Epi > NE > Iso > DA > Doba |
|
|
Term
|
Definition
Pre-synaptic nerve terminals |
|
|
Term
|
Definition
Increased HR, conduction, and contractility
Renin release from the JGA
Iso > Epi > NE > DA > Dobu |
|
|
Term
|
Definition
Dilation of skeletal muscle BV
Dilation of ab viscera BV
Decreased GI tone, increased motility, and secretion
Bladder relaxation
Uterine relaxation
Epi > NE > Iso > DA > Doba |
|
|
Term
|
Definition
Low dose: Beta 1 and Beta 2
High dose: Alpha 1
Beta 1: increased automaticity, rate, conduction, CO
Beta 2: decrease BP (low dose), bronchodilation, glycogen breakdown
Alpha 1: increase BP (high dose), bronchodilation, decreased glycogen synthesis, and decreased insulin secretion
Used in anaphylactic shock, hypersensitivity reaction, cardiac arrest |
|
|
Term
|
Definition
Neurotransmitter in postganglionic sympathetic neurons
Same effects on heart as epi
Increased BP (Alpha 1) with no change in cardiac output
Used in cases of shock and spinal anesthesia |
|
|
Term
|
Definition
Non-endogenous selective Beta agonist
Beta 1: Increase HR, etc
Beta 2: Decrease BP (vasodilation), bronchodilation
Used in emergent heart block, in preparation for a pacemaker, or to relax bronchi if Beta 2 selective agonist is not available
Will not cross BBB |
|
|
Term
|
Definition
Dopamine receptor, Beta 1, and Beta 2
High dose: Alpha 1
Beta 1: increases HR
BP net decreases due to above receptors
Used in cardiogenic shock
Side effects: excessive sympathetic stimulation and excessive dopamine stimulation (CTZ)
No CNS effects |
|
|
Term
|
Definition
Low dose: Beta 1
High dose: Beta 2, Alpha 1
Beta 1: Increase in HR but not contractility
Alpha 1: Increase in BP at high doses
Used in heart failure, open heart surgery, or acute MI
Side effects: Arrhythmias
A sympathomimetic
Does not cross BBB |
|
|
Term
|
Definition
An alpha agonist primarily selective for Alpha 1
Decongestion of mucous membranes and pupillary dilation
Side effects: excessive stimulation can elevate BP
Not metabolized by MAO or COMT |
|
|
Term
|
Definition
A weak Alpha and Beta agonist
Decongestion of mucous membranes and increase in BP
Used as a nasal decongestant, pressor, and for CNS stimulation
Side effects: CNS efects
Not metabolized by MAO or COMT |
|
|
Term
Terbutaline and Albuterol |
|
Definition
Relatively selective for Beta 2
Bronchodilation
Used in asthma
Side effects: high doses can activate Beta 1 and cause heart effects |
|
|
Term
|
Definition
A CNS stimulant that encourages the release of NE from the nerve terminal via facilitated exchange
Used in narcolepsy and weight reduction
Side effects: CNS stimulation, PV effects, risk of abuse
Not metabolized by MAO or COMT |
|
|
Term
|
Definition
CNS stimulant that encourage release of NE from the nerve terminal via faciliated exchange
Used in ADHD
Side effects: excess CNS stimulation, PV effects, risk of abuse |
|
|
Term
|
Definition
Inhibits PDE and adenosine to cause sympathomimetic effect without adrenergic receptor binding
Works downstream from cAMP to allow intracellular build up of NE
Causes sensitization of cortex, respiratory area, increased HR, contractility, dilation of BV, and cerebral vascular constriction
Used in alterness and relief of headache
|
|
|
Term
|
Definition
Inhibits PDE and adenosine to cause sympathomimetic effect without adrenergic receptor binding
Works downstream from cAMP to allow intracellular build up of NE
Causes sensitization of cortex, respiratory area, increased HR, contractility, dilation of BV, and cerebral vascular constriction
Used bronchial asthma with Beta 2
Has less effects on heart and lungs, more CNS
|
|
|
Term
|
Definition
Reversible selective Alpha 1 antagonist
Decreases BP with reflex tachycardia
Used in HTN and BPH
Side effects: postural hypotension, inhibition of ejaculation, nasal stuffiness |
|
|
Term
|
Definition
Irreversible selective Alpha 1 antagonist
Binds covalently for 24 hours
Used in pheochromocytoma (with propanolol)
Side effects: postural hypotension, reflex tachycardia, inhibition of ejaculation |
|
|
Term
|
Definition
Non-selective alpha antagonist
Alpha 1: decrease BP
Alpha 2: prevents feedback inhibition of NE
Causes greater reflex tachycardia due to Beta 1 stimulation
Used in pheochromocytoma with propanolol |
|
|
Term
|
Definition
Non-selective Beta antagonist
Beta 1: decrease HR, contractility, conduction, renin
Beta 2: increase TPR, slow recovery from hypoglycemia, increased TG/VLDL, increased airway resistance
Causes NET decrease in BP
Used in HTN, cardiac arrhythmias, angina, glaucoma, MI, Pheo, heart failure, performance anxiety
Side effects: decreased CO, heart block, bronchospasm, CNS effects |
|
|
Term
|
Definition
Non-selective Beta antagonist
Decrease in aqueous humor production
Same uses as Propanolol |
|
|
Term
|
Definition
Selective Beta 1 antagonist
Decreases HR, CO, conduction, renin
Also affects Beta 2 at high doses
Used for same reasons as propanolol
Same adverse effects as propanolol
Has less respiratory effects than non-selectives |
|
|
Term
|
Definition
Most selective Beta 1 antagonist
Same effects and indications of propanolol
Has an 8 minute half life
Less respiratory effects than non-selectives |
|
|
Term
|
Definition
Alpha 2 agonist
Binds to Alpha 2 to produce feedback inhibition of NE
Blocks sympathetic outflow
Used in essential HTN, reduction of opioid withdrawal, OAG, and ADHD
Side effects: dry mouth, sedation, HTN crisis
|
|
|
Term
|
Definition
Binds to Alpha 2 to produce feedback inhibition of NE
Blocks sympathetic outflow
Used in essential HTN
Side effects: autoimmune response
Is a prodrug that is safe to use to pregnancy |
|
|
Term
|
Definition
Enters the pre-synaptic terminal via diffusion
Blocks VMAT and depletes NE |
|
|
Term
|
Definition
Enters the pre-synaptic terminal via the NET
Uncouples the AP from Ca entry
Concentrated in NE vesicles and depletes NE
|
|
|
Term
|
Definition
Substrate for NET
Enters pre-synaptic nerve terminal
Displaces NE via facilitated exchange so that NE is release |
|
|
Term
Cocaine, Imipramine, Atomoxetine |
|
Definition
Blocks the NET (Atomoxine is selective) to increase NE in the synapse |
|
|
Term
|
Definition
Carbonic anhydrase inhibitor that works at the proximal tubule
Prevents reabsorption of HCO3-
Decreases H+ secretion
Decreases production of aqueous humor
Used in OAG, urinary alkalinization, metabolic alkalosis, acute mountain sickness, epilepsy
Side effects: hyperchloremic acidosis, hypersensitivity with sulfas
Urine: increased HCO3-, Na+, K+, decreased Cl-
Blood: increased H+ |
|
|
Term
|
Definition
Most commonly used diuretic that works at the distal convoluted tubule
Inhibits the NaCl anti-port
Produces a hyperosmolar urine
Used in HTN, CHF, hypercalciuria, and nephrogenic DI
Works as ADH substitute
Side effects: hyperkalemia, hypercalcemia, hypochloremic acidosis, increased TG/VLDL
Urine: increased Na+, Cl-, K+, decreased Ca++
Blood: hypokalemia |
|
|
Term
|
Definition
Most efficaceous diuretic
Inhibits the NKCC and disrupts the positive lumen potential, causes diminished Mg and Ca reabsorption
Inhibits a concentrated or dilute urine
Decreases renal vascular resistance
Used in pulmonary edema, hyperkalemia, acute renal failure
Contraindicated with quinidine, hypersensitivity with sulfas
Urine: increased NaCl, K, H, Mg, Ca, HCO3-
Blood: hypokalemic alkalosis, hypochloremia |
|
|
Term
|
Definition
Aldosterone antagonist that only works in the presence of aldosterone
Prevents insertion of Na+ channels in CD
Used to retain K, aldosteronism
Side effects: hyperglycemia, gynecomastia, menstrual irregularities
Causes increased secretion of NaCl and hyperkalemia |
|
|
Term
|
Definition
K sparing diuretic that does not require aldosterone.
Works at the CD to block Na channels
Used in conjunction with furosemide or hydrochlorothiazide or prevent hypokalemia
Induces P450 |
|
|
Term
|
Definition
An osmotic diuretic that is freely filtered
Works at water permeable segments (PT, DL, CD)
Increases osmotic activity of solute, preventing water reabsorption and favoring secretion
Increases RBF, and decreases corticomedullary gradient
Used in AKI, acute glaucoma, dialysis
Decreases osmolarity of urine
|
|
|
Term
|
Definition
Non-peptide ADH antagonist that works at the collecting tubule basolateral membrane
Used in SIADH, hyponatremia, and CHF
Side effect: hypernatremia
Increased urine volume with decreased osmolarity |
|
|
Term
First Generation H1 Antagonists |
|
Definition
Chlorpheniramine
Diphenhydramine
Dimenhydrinate
Used in OTC medications, anti-motion sickness, and sleep aid |
|
|
Term
Second generation H1 Antagonists |
|
Definition
Loratadine
Fexofenadine
Metabolized by CYP3A4
Longer lasting
Less CNS effects
Used for allergic rhinitis |
|
|
Term
|
Definition
Cimetidine
Rantidine
Famotidine
Prevent histamine stimulated acid secretion
Used in ulcers, GERD, Zollinger-Ellison syndrome
Side effects: prolactin, impotence, gyncomastia
Can suppress first pass effect of alcohol |
|
|
Term
|
Definition
Prevents mast cell degranulation
Used in allergic rhinitis
Side effects: itching, sneezing, and headache |
|
|